Genomic Considerations in the Treatment of Thyroid Carcinoma.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38621192.
- Also identified by DOI 10.1200/OP.24.00198.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Highlighting genomically driven targeted therapies to improve outcomes in advanced thyroid carcinoma.
Medical subject headings
- Thyroid Neoplasms
- Genomics